Safety and Efficacy Study of Pregabalin in Fibromyalgia
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin
reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if
different dosages work better (reduce pain and mild to no side effects) for different people.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.